Renal Cell Carcinoma Clinical Trials | A Deep Dive into the Latest Advancements
https://vimeo.com/925122237 What’s the latest in renal cell carcinoma clinical trial news? Expert Dr. Moshe Ornstein from Cleveland Clinic discusses updates on antibody drug conjugates, targeted therapy, checkpoint inhibitors, bispecific antibodies, vascular endothelial…
Exploring Renal Cell Carcinoma Research: Expert Insights on Immunotherapy and Targeted Therapy
https://vimeo.com/925122081 What’s important in renal cell carcinoma research news? Expert Dr. Moshe Ornstein from Cleveland Clinic shares an overview of research updates on immunotherapy, targeted therapy, and combination therapies. Download Resource Guide…
Advancing Equity | Research Initiatives in AML Disparities Among Black and Latinx Populations
https://vimeo.com/925588114 What AML research efforts are underway to advance equity among Black and Latinx and populations? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses initiatives that are working to improve AML…
Do AML Patients Receive Allo or Auto Stem Cell Transplant?
https://vimeo.com/925582477 What type of stem cell transplant do AML patients receive? Expert Dr. Sara Taveras Alam from UTHealth Houston explains stem cell transplant for AML care and advice to help patients locate…
How Can AML Patients Benefit From Shared Decision-Making?
https://vimeo.com/925582413 How can shared decision-making benefit AML patient care? Expert Dr. Sara Taveras Alam from UTHealth Houston explains how she works to set patient expectations from diagnosis and throughout the treatment journey…
AML Diagnosis Disparities | Factors Impacting Underrepresented Racial and Ethnic Groups
https://vimeo.com/925582366 What factors contribute to AML diagnosis disparities? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses disparity factors in underrepresented patient groups and patient advice for newly diagnosed AML patients. [ACT]IVATION…
How Do AML Patients and Outcomes Differ by Population Groups?
https://vimeo.com/925579574 How do AML genetic and molecular subtypes vary by population groups, and what are the impacts? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses AML characteristics that impact some population…
Black and Latinx AML Patients | The Impact of Cultural Beliefs
https://vimeo.com/925566915 What impact can cultural beliefs have for Black, Latinx, and other AML patients? Expert Dr. Sara Taveras Alam from UTHealth Houston explains how experiences, cultural beliefs, and religious beliefs can impact…
How Can Bone Marrow Biopsies Be Used in AML Care?
https://vimeo.com/925566838 How do AML care providers use bone marrow biopsies in patient care? Expert Dr. Sara Taveras Alam from UTHealth Houston explains how the tests are used and shares patient advice for…
AML Clinical Trial Participation Disparities | Impact on Access, Outcomes, and Inclusion Strategies
https://vimeo.com/925566796 What are AML clinical trial disparities, outcomes, and solutions for inclusion? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses patient factors that impact access, underrepresented patient groups, and patient advice…
How Is AML Care Impacted by Bone Marrow Biopsy Results?
https://vimeo.com/925566573 What is the impact of bone marrow biopsy results on AML care? Expert Dr. Sara Taveras Alam from UTHealth Houston shares how test results are weighed along with patient factors to…
AML Diagnosis | Exploring Bone Marrow Biopsy and Alternatives
https://vimeo.com/925566047 What are the purpose and alternatives to bone marrow biopsy? Expert Dr. Sara Taveras Alam from UTHealth Houston explains what’s involved in bone marrow biopsy, what is analyzed, patient advice for…